Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Abbott Laboratories before investing.

In this article, we go over a few key elements for understanding Abbott Laboratories’s stock price such as:

• Abbott Laboratories’s current stock price and volume
• Why Abbott Laboratories’s stock price changed recently
• Upgrades and downgrades for ABT from analysts
• ABT’s stock price momentum as measured by its relative strength

About Abbott Laboratories (ABT)

Before we jump into Abbott Laboratories’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.

Want to learn more about Abbott Laboratories’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Abbott Laboratories.

Abbott Laboratories’s Stock Price as of Market Close

As of July 18, 2024, 4:00 PM, CST, Abbott Laboratories’s stock price was $100.07.

Abbott Laboratories is down 4.4% from its previous closing price of $104.68.

During the last market session, Abbott Laboratories’s stock traded between $102.50 and $105.65. Currently, there are 1,740.20 million shares of Abbott Laboratories stock available for purchase.

Abbott Laboratories’s price-earnings (P/E) ratio is currently at 32.5, which is low compared to the Medical Equipment, Supplies & Distribution industry median of 39.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Abbott Laboratories Stock Price History

Abbott Laboratories’s (ABT) price is currently down 3.7% so far this month.

During the month of July, Abbott Laboratories’s stock price has reached a high of $105.65 and a low of $99.71.

Over the last year, Abbott Laboratories has hit prices as high as $121.64 and as low as $89.67. Year to date, Abbott Laboratories’s stock is down 8.85%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Abbott Laboratories Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 17, 2024, there were 2 analysts who downgraded Abbott Laboratories’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Abbott Laboratories’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Abbott Laboratories’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Abbott Laboratories’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Abbott Laboratories (ABT) by visiting AAII Stock Evaluator.

Relative Price Strength of Abbott Laboratories

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 17, 2024, Abbott Laboratories has a weighted four-quarter relative price strength of -6.16%, which translates to a Momentum Score of 41 and is considered to be Average.

Want to learn more about how Abbott Laboratories is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Abbott Laboratories Stock Price: Bottom Line

As of July 18, 2024, Abbott Laboratories’s stock price is $100.07, which is down 4.4% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Abbott Laboratories stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.